AbbVie registers Phase 1 trial comparing upadacitinib, tofacitinib, baricitinib in healthy adultsSep 30Weekly roundup, 4 itemsABBV-722AbbVie
ADARx Pharmaceuticals closes IPO and AbbVie private placementSep 28FinancingAbbVieADARx Pharmaceuticals, Inc.
AbbVie registers first-in-human Phase 1 trial for oral ABBV-1162Sep 25Weekly roundup, 2 itemsABBV-1162AbbVieUpdated
ADARx prices IPO at $17 per share, AbbVie to buy stakeSep 25FinancingAbbVieADARx Pharmaceuticals, Inc.
AbbVie registers Phase 3 trial of telisotuzumab adizutecan in NSCLCSep 16Trial updateAbbVietelisotuzumab adizutecan
AbbVie sponsors new ABBV-253 solid tumor trial; collaborates on epcoritamab lymphoma studySep 10Weekly roundup, 2 itemsABBV-253AbbVie
AbbVie posts IMGN632 BPDCN results; opens NOA LIFT filler trial vs VOLIFTSep 4Weekly roundup, 4 itemsAbbVieIMGN632
AbbVie closes $10.9 billion acquisition of Apogee Therapeutics, reaffirms 2026 guidanceSep 3M&AAbbVie
AbbVie registers Phase 3 trial of etentamig vs Dara-CyBorD in AL amyloidosisAug 28Trial updateAbbViedexamethasone
AbbVie posts results from terminated emraclidine trial, opens two studies to recruitmentAug 21Weekly roundup, 4 itemsAbbVieemraclidine
AbbVie posts Crohn's OLE results; registers Phase 3 lung cancer and Phase 1 glabellar lines trialsAug 13Weekly roundup, 3 itemsABBV-1480AbbVie
AbbVie registers three new trials spanning obesity, head and neck cancer, and atopic dermatitisAug 7Weekly roundup, 3 itemsABBV-295AbbVie
Regenxbio reports Q2 2026 results, cites Duchenne trial win and new AbbVie fundsAug 6Quarterly updateAbbVieREGENXBIO Inc.
Ironwood raises 2026 guidance again as apraglutide trial recruits and debt is repaidAug 6Quarterly updateAbbVieIronwood Pharmaceuticals Inc
AbbVie to acquire Apogee Therapeutics, updates 2026 EPS guidance amid Q2 resultsJul 31Quarterly updateAbbVie
AbbVie week: BOTOX oral pain results post; new CLL, myeloma, ABBV-859 trials filedJul 31Weekly roundup, 6 itemsABBV-859AbbVie
AbbVie registers two real-world studies for atogepant and mirvetuximab soravtansine-gynxJul 8Weekly roundup, 2 itemsAbbVieatogepant
Sign in